AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.92
+0.14
(+1.05%)
Pre-Market: 08:18
AbCellera Biologics Shareholders Equity (Quarterly) : 896.02M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 896.02M |
| March 31, 2026 | 938.08M |
| December 31, 2025 | 966.90M |
| September 30, 2025 | 964.04M |
| June 30, 2025 | 1.007B |
| March 31, 2025 | 1.023B |
| December 31, 2024 | 1.056B |
| September 30, 2024 | 1.078B |
| June 30, 2024 | 1.111B |
| March 31, 2024 | 1.130B |
| December 31, 2023 | 1.152B |
| September 30, 2023 | 1.183B |
| June 30, 2023 | 1.195B |
| Date | Value |
|---|---|
| March 31, 2023 | 1.208B |
| December 31, 2022 | 1.233B |
| September 30, 2022 | 1.250B |
| June 30, 2022 | 1.213B |
| March 31, 2022 | 1.208B |
| December 31, 2021 | 1.026B |
| September 30, 2021 | 953.40M |
| June 30, 2021 | 967.68M |
| March 31, 2021 | 957.12M |
| December 31, 2020 | 830.51M |
| September 30, 2020 | 89.24M |
| June 30, 2020 | 90.89M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| MindWalk Holdings Corp. | 4.926M |
| Repligen Corp. | 2.112B |
| Bio-Techne Corp. | 2.108B |
| Aurinia Pharmaceuticals, Inc. | 614.86M |
| BioLife Solutions, Inc. | 420.00M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.308B |
| Total Liabilities (Quarterly) | 233.30M |
| Debt to Equity Ratio | 0.1514 |
| Current Ratio | 12.77 |
| Net Debt Paydown Yield | -0.56% |